Pulmonary involvement in inflammatory bowel disease

World Journal of Gastroenterology

Volumn 16, Issue 39, 2010, Pages 4952-4957

  Yilmaz, Aydin ^a   Demirci, Nilgü n Yilmaz ^a   Hoşgün, Derya ^b   Üner, Enver ^c   Erdoǧan, Yurdanur ^a   Gökçek, Atila ^a   Çaǧlar, Atalay ^d  

^a Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^b Agri Public Hospital   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Crohn's disease; High resolution computed tomography; Inflammatory bowel disease; Lung diseases; Pulmonary function tests; Ulcerative colitis

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE; IMMUNOGLOBULIN E;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; ENDOSCOPY; ENTERITIS; FEMALE; FORCED EXPIRATION; FORCED VITAL CAPACITY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MALE; ULCERATIVE COLITIS;

EID: 78049519289     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i39.4952     Document Type: Article

References (24)

1. Baumgart DC. The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis. Dtsch Arztebl Int 2009; 106: 123-133
2. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007; 131: 524-532
3. Camus P, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000; 15: 5-10
4. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Br Med J 1955; 2: 1041-1048
5. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82-86
6. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444
7. Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000; 15: 41-48
8. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlén B, DiMaria G, Foresi A, Hargreave FE, Holgate ST, Inman M, Lötvall J, Magnussen H, Polosa R, Postma DS, Riedler J; ERS Task Force. ERS Task Force. Indirect airway challenges. Eur Respir J 2003; 21: 1050-1068
9. Kraft SC, Earle RH, Rossler M, Estarly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976; 136: 454-459
10. Godet PG, Cowie R, Woodman RC, Sutherland LR. Pulmonary function abnormalities in patients with ulcerative colitis. Am J Gastroenterol 1997; 92: 1154-1156
11. Mohamed-Hussein AA, Mohamed NA, Ibrahim ME. Changes in pulmonary function in patients with ulcerative colitis. Respir Med 2007; 101: 977-982
12. Tzanakis N, Samiou M, Bouros D, Mouzas J, Kouroumalis E, Siafakas NM. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med 1998; 157: 382-386
13. Corrin B. Pulmonary manifestations of systemic disease. In: Corrin B, editor. Pathology of the lungs. London: Harcourt Publishers, 2000: 423-446
14. Webb RW. Normal Lung Anatomy. In: Webb RW, Müler LN, Naidich PD, editors. High-Resolution CT of The Lung. Philadelphia: Lippincott Williams and Wilkins, 2001: 49-70
15. Omori H, Asahi H, Inoue Y, Irinoda T, Saito K. Pulmonary involvement in Crohn's disease report of a case and review of the literature. Inflamm Bowel Dis 2004; 10: 129-134
16. Peters FP, Englels LG, Moers AM. Pneumonitis induced by sulphasalazine. Postgrad Med J 1997; 73: 99-100
17. Zamir D, Weizman J, Zamir C, Fireman Z, Weiner P. Mesalazine induced hypersensitivity pneumonitis. Harefuah 1999; 137: 28-30, 87, 86
18. Kuzela L, Vavrecka A, Prikazska M, Drugda B, Hronec J, Senkova A, Drugdova M, Oltman M, Novotna T, Brezina M, Kratky A, Kristufek P. Pulmonary complications in patients with inflammatory bowel disease. Hepatogastroenterology 1999; 46: 1714-1719
19. Marvisi M, Borrello PD, Brianti M, Fornarsari G, Marani G, Guariglia A. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000; 16: 965-968
20. Douglas JG, McDonald CF, Leslie MJ, Gillon J, Crompton GK, McHardy GJ. Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? Respir Med 1989; 83: 389-394
21. Songür N, Songür Y, Tüzün M, Doǧan I, Tüzün D, Ensari A, Hekimoglu B. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol 2003; 37: 292-298
22. Ceyhan BB, Karakurt S, Cevik H, Sungur M. Bronchial hyperreactivity and allergic status in inflammatory bowel disease. Respiration 2003; 70: 60-66
23. Louis E, Louis R, Drion V, Bonnet V, Lamproye A, Radermecker M, Belaiche J. Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy 1995; 50: 729-733
24. Christie PM, Hill GL. Effect of intravenous nutrition on nutrition and function in acute attacks of inflammatory bowel disease. Gastroenterology 1990; 90: 730-736